Toronto, Ontario–(Newsfile Corp. – September 19, 2025) – Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “Telo”), a leader in the development of diagnostic and prognostic tests for human disease through the analysis of telomeres, today announced that the company has presented a poster abstract on minimal residual …
Read More »
Matribhumi Samachar English